VAMP5 Antibody, Biotin conjugated
-
中文名稱：VAMP5兔多克隆抗體, Biotin偶聯(lián)
-
貨號：CSB-PA025784LD01HU
-
規(guī)格：￥880
-
其他：
產(chǎn)品詳情
-
產(chǎn)品名稱：Rabbit anti-Homo sapiens (Human) VAMP5 Polyclonal antibody
-
Uniprot No.：
-
基因名：VAMP5
-
別名：VAMP5; HSPC191; Vesicle-associated membrane protein 5; VAMP-5; Myobrevin
-
宿主：Rabbit
-
反應(yīng)種屬：Human
-
免疫原：Recombinant Human Vesicle-associated membrane protein 5 protein (1-72AA)
-
免疫原種屬：Homo sapiens (Human)
-
標(biāo)記方式：Biotin
-
克隆類型：Polyclonal
-
抗體亞型：IgG
-
純化方式：>95%, Protein G purified
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 -
產(chǎn)品提供形式：Liquid
-
應(yīng)用范圍：ELISA
-
Protocols：
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產(chǎn)品評價
相關(guān)產(chǎn)品
靶點詳情
-
功能：May participate in trafficking events that are associated with myogenesis, such as myoblast fusion and/or GLUT4 trafficking.
-
基因功能參考文獻：
- VAMP5 polymorphisms were found to be associated with the total colonic aganglionosis of Hirschsprung disease. PMID: 26970437
- Our findings indicate that VAMP5 and VAMP8 are not involved in POAG in the Dutch population. PMID: 16110299
-
亞細胞定位：Cell membrane; Single-pass type IV membrane protein. Endomembrane system; Single-pass type IV membrane protein. Golgi apparatus, trans-Golgi network membrane; Single-pass type IV membrane protein.
-
蛋白家族：Synaptobrevin family
-
數(shù)據(jù)庫鏈接：
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
